相似文献
1
PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.
Blood. 2008 Nov 1;112(9):3777-87. doi: 10.1182/blood-2008-01-134122. Epub 2008 Aug 11.
2
Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
EMBO J. 2006 Sep 6;25(17):3955-65. doi: 10.1038/sj.emboj.7601273. Epub 2006 Aug 17.
3
Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1.
Cancer Cell. 2010 May 18;17(5):455-68. doi: 10.1016/j.ccr.2010.03.022.
4
Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice.
Leukemia. 2015 Aug;29(8):1771-8. doi: 10.1038/leu.2015.58. Epub 2015 Mar 6.
5
Core binding factor genes and human leukemia.
Haematologica. 2002 Dec;87(12):1307-23.
6
PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.
Mol Cell Biol. 2008 Dec;28(23):7126-38. doi: 10.1128/MCB.00897-08. Epub 2008 Sep 22.
7
Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta.
Chem Biol. 2007 Oct;14(10):1186-97. doi: 10.1016/j.chembiol.2007.09.006.
8
Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation.
Mol Cell Biol. 1998 Jul;18(7):4252-61. doi: 10.1128/MCB.18.7.4252.
9
Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation.
EMBO J. 2001 Feb 15;20(4):723-33. doi: 10.1093/emboj/20.4.723.
10
Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14592-7. doi: 10.1073/pnas.1200037109. Epub 2012 Aug 21.
引用本文的文献
1
DYRK1A in blood and immune function: implications in leukemia, inflammatory disorders, infection and Down syndrome.
Front Cell Dev Biol. 2025 May 30;13:1587089. doi: 10.3389/fcell.2025.1587089. eCollection 2025.
2
CDK9 phosphorylates RUNX1 to promote megakaryocytic fate in megakaryocytic-erythroid progenitors.
Blood. 2024 Oct 24;144(17):1800-1812. doi: 10.1182/blood.2024023963.
3
The Sweet Side of HIPK2.
Cancers (Basel). 2023 May 9;15(10):2678. doi: 10.3390/cancers15102678.
4
The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context.
Cells. 2023 Feb 16;12(4):641. doi: 10.3390/cells12040641.
5
Integrative in silico and in vitro transcriptomics analysis revealed new lncRNAs related to intrinsic apoptotic genes in colorectal cancer.
Cancer Cell Int. 2020 Nov 10;20(1):546. doi: 10.1186/s12935-020-01633-w.
6
Inactivation of homeodomain-interacting protein kinase 2 promotes oral squamous cell carcinoma metastasis through inhibition of P53-dependent E-cadherin expression.
Cancer Sci. 2021 Jan;112(1):117-132. doi: 10.1111/cas.14691. Epub 2020 Nov 9.
7
Chromatin Targeting of HIPK2 Leads to Acetylation-Dependent Chromatin Decondensation.
Front Cell Dev Biol. 2020 Sep 1;8:852. doi: 10.3389/fcell.2020.00852. eCollection 2020.
8
Benzodiazepines Drive Alteration of Chromatin at the Integrated HIV-1 LTR.
Viruses. 2020 Feb 9;12(2):191. doi: 10.3390/v12020191.
9
RUNX1 Dosage in Development and Cancer.
Mol Cells. 2020 Feb 29;43(2):126-138. doi: 10.14348/molcells.2019.0301.
10
Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription.
Cancers (Basel). 2019 Dec 7;11(12):1973. doi: 10.3390/cancers11121973.
本文引用的文献
1
RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes.
Adv Cancer Res. 2008;99:33-76. doi: 10.1016/S0065-230X(07)99002-8.
2
Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult.
Stem Cells. 2007 Dec;25(12):2976-86. doi: 10.1634/stemcells.2007-0061. Epub 2007 Sep 6.
3
Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription.
Oncogene. 2007 Nov 8;26(51):7231-9. doi: 10.1038/sj.onc.1210523. Epub 2007 May 28.
4
HIPK2: a versatile switchboard regulating the transcription machinery and cell death.
Cell Cycle. 2007 Jan 15;6(2):139-43. doi: 10.4161/cc.6.2.3788. Epub 2007 Jan 29.
5
Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia.
Blood. 2007 May 1;109(9):4023-7. doi: 10.1182/blood-2006-01-031781. Epub 2007 Jan 23.
6
AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex.
Mol Cell Biol. 2006 Oct;26(20):7420-9. doi: 10.1128/MCB.00597-06. Epub 2006 Aug 5.
7
Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
EMBO J. 2006 Sep 6;25(17):3955-65. doi: 10.1038/sj.emboj.7601273. Epub 2006 Aug 17.
8
Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals.
Mol Cell Biol. 2006 Apr;26(7):2758-71. doi: 10.1128/MCB.26.7.2758-2771.2006.
9
Biological implications of filamin A-bound PEBP2beta/CBFbeta retention in the cytoplasm.
Crit Rev Eukaryot Gene Expr. 2005;15(3):197-206. doi: 10.1615/critreveukargeneexpr.v15.i3.20.
10
AML1 deletion in adult mice causes splenomegaly and lymphomas.
Oncogene. 2006 Feb 9;25(6):929-39. doi: 10.1038/sj.onc.1209136.
Zotero 插件